U.S. Capital Wealth Advisors LLC Decreases Stock Position in Cencora, Inc. $COR

U.S. Capital Wealth Advisors LLC decreased its position in Cencora, Inc. (NYSE:COR) by 33.2% in the 4th quarter, Holdings Channel reports. The fund owned 5,714 shares of the company’s stock after selling 2,844 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Cencora were worth $1,930,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Choreo LLC increased its stake in Cencora by 5.3% during the 4th quarter. Choreo LLC now owns 4,236 shares of the company’s stock worth $1,440,000 after buying an additional 215 shares during the period. Carnegie Investment Counsel lifted its holdings in Cencora by 12.1% in the 4th quarter. Carnegie Investment Counsel now owns 1,704 shares of the company’s stock worth $576,000 after buying an additional 184 shares in the last quarter. Venturi Wealth Management LLC boosted its position in Cencora by 2.2% in the 4th quarter. Venturi Wealth Management LLC now owns 3,258 shares of the company’s stock valued at $1,100,000 after buying an additional 69 shares during the last quarter. Bartlett & CO. Wealth Management LLC grew its stake in shares of Cencora by 2.8% during the fourth quarter. Bartlett & CO. Wealth Management LLC now owns 4,726 shares of the company’s stock valued at $1,596,000 after acquiring an additional 130 shares in the last quarter. Finally, Premier Path Wealth Partners LLC grew its stake in shares of Cencora by 7.2% during the fourth quarter. Premier Path Wealth Partners LLC now owns 1,498 shares of the company’s stock valued at $506,000 after acquiring an additional 100 shares in the last quarter. 97.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently commented on COR shares. Robert W. Baird set a $415.00 price target on Cencora in a research note on Tuesday, January 13th. Barclays lifted their price objective on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Bank of America reduced their target price on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a research note on Monday, January 5th. Morgan Stanley set a $380.00 price target on shares of Cencora in a research note on Tuesday, March 17th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Twelve investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $398.17.

Cencora Trading Down 0.5%

Cencora stock opened at $317.40 on Tuesday. Cencora, Inc. has a 1 year low of $271.00 and a 1 year high of $377.54. The firm’s 50-day moving average is $344.46 and its 200-day moving average is $342.97. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. The company has a market cap of $61.74 billion, a P/E ratio of 38.13, a PEG ratio of 1.50 and a beta of 0.72.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. During the same quarter in the prior year, the firm earned $3.73 EPS. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. On average, equities analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio is presently 28.85%.

Insider Activity

In related news, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer owned 66,726 shares in the company, valued at $23,669,713.98. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.38% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.